Skip to main navigation Skip to search Skip to main content

Optic atrophy, cataracts, lipodystrophy/lipoatrophy, and peripheral neuropathy caused by a de novo OPA3 mutation

  • Stephanie C. Bourne
  • , Katelin N. Townsend
  • , Casper Shyr
  • , Allison Matthews
  • , Scott A. Lear
  • , Raj Attariwala
  • , Anna Lehman
  • , Wyeth W. Wasserman
  • , Clara van Karnebeek
  • , Graham Sinclair
  • , Hilary Vallance
  • , William T. Gibson
  • pre-AMC

Research output: Contribution to journalArticleAcademicpeer-review

7 Downloads (Pure)

Abstract

We describe a woman who presented with cataracts, optic atrophy, lipodystrophy/lipoatrophy, and peripheral neuropathy. Exome sequencing identified a c.235C > G p.(Leu79Val) variant in the optic atrophy 3 (OPA3) gene that was confirmed to be de novo. This report expands the severity of the phenotypic spectrum of autosomal dominant OPA3 mutations
Original languageEnglish
Pages (from-to)a001156
JournalCold Spring Harbor molecular case studies
Volume3
Issue number1
DOIs
Publication statusPublished - 2017

Fingerprint

Dive into the research topics of 'Optic atrophy, cataracts, lipodystrophy/lipoatrophy, and peripheral neuropathy caused by a de novo OPA3 mutation'. Together they form a unique fingerprint.

Cite this